← Open Payments lookup

KRISTINE FISHER: Open Payments

NPI 1003515792 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$424 in 16 payments from 12 companies in 2025. Trend: 2023 $370 · 2024 $574 · 2025 $424

Food & beverage: $424
CompanyPaymentsAmount
GlaxoSmithKline, LLC.3$80
Merck Sharp & Dohme LLC3$69
JAZZ PHARMACEUTICALS INC.1$39
Takeda Pharmaceuticals U.S.A., Inc.1$34
Janssen Biotech, Inc.1$31
Iovance Biotherapeutics, Inc.1$28
PharmaEssentia USA Corporation1$28
Incyte Corporation1$25
Gilead Sciences, Inc.1$25
Caris MPI, Inc.1$23

Products named: KEYTRUDA, OJJAARA, ZEPZELCA, FRUZAQLA, RYBREVANT, JEMPERLI, Amtagvi, BESREMI.

Industry payments across MD — which companies pay providers there.